title: The nursing process in photodynamic therapy.
abstract: The results from the TAP Study have been found to be significant, but remember this is not a cure. There are no quick and easy solutions to this devastating disease, which can creep up so suddenly and without warning. Ophthalmologists may be able to stabilize the vision without allowing it to become worse, but the key words are "without allowing it to become worse." Unfortunately, to most patients, it is already worse. Nurses must address the patients' feelings and concerns first, before offering a physical solution that is only a temporary "band aid." After 10 years of working in the area of ophthalmology, specifically low vision, it has come to the authors' attention that a large percentage of patients suffering from AMD display depressive symptoms such as feelings of sadness, worthlessness, and hopelessness, and low self-esteem. Many appear to go through a grieving process. Keeping this is mind, the overall goal in nursing care should be to help patients with AMD use available resources so they have the potential to maintain a satisfying quality of life, physically and emotionally.
authors.affiliation: Department of Ophthalmology, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: B
authors.initials: B
authors.lastname: Sahota
authors.forename: M J
authors.initials: MJ
authors.lastname: Potter
mesh_terms: D000368:Aged; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology / Q000451:nursing*; D002986:Clinical Trials as Topic; D006801:Humans; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy / Q000451:nursing*; D008875:Middle Aged; D009736:Nursing Process / Q000458:organization & administration*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use; D011166:Porphyrins / Q000627:therapeutic use; D000077362:Verteporfin
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin